Despite minimal hemodynamic alterations endotoxemia modulates NOS and p38-MAPK phosphorylation via metalloendopeptidases

Molecular and Cellular Biochemistry

Volumn 265, Issue 1-2, 2004, Pages 47-56

  Gupta, Akanksha ^a   Sharma, Avadhesh C ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Cytokine; Endothelin; Lipopolysaccharide; Signaling; Systemic hemodynamic; TNF

Indexed keywords

ENDOTHELIN 1; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE SYNTHASE; PHOSPHORAMIDON; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOPEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEMODYNAMICS; INFLAMMATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THORACIC AORTA; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD PRESSURE; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ENZYMOLOGY; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; SPRAGUE DAWLEY RAT; TIME; UPREGULATION;

ANIMALIA;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CYTOKINES; ENDOTHELIN-1; ENDOTOXEMIA; GLYCOPEPTIDES; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; MALE; METALLOENDOPEPTIDASES; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; UP-REGULATION;

EID: 14744291203     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000044314.29395.fb     Document Type: Article

References (29)

1. Glauser MP, Zannetti G, Baumgartner J-D, Cohen J: Septic shock: pathogenesis. Lancet 338: 732-736, 1991
2. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parillo JE: The cardiovascular response of normal humans to the administration of endotoxin. New Engl J Med 321: 280-287, 1989
3. Nakaki T, Otsuka Y, Nakayama M, Kato R: Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur J Pharmacol 219: 311-318, 1992
4. Sharma AC, Sam II AD, Alden KJ, Moore S, Law WR, Ferguson JL: Central versus peripheral mediation of naloxone's perfusion effects in endotoxic rats. Shock 14: 441-446, 2000
5. Olsson LE, Wheeler MA, Secca WC, Weiss RM: Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide upregulate cytokines and iNOS in rat urinary bladder. J Pharmacol Exp Ther 284: 1203-1208, 1998
6. 2+-independent nitric oxide synthesis. FEBS Lett 291: 145-149, 1991.
7. Stein B, Frank P, Schmitz W, Scholz H, Thoenes M: Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 28: 1631-1639, 1996
8. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayishi Y, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent, vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
9. Guha M and Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 13: 85-94, 2001
10. Sharma AC, Motew SJ, Farias S, Alden KJ, Bosmann HB, Law WR, Ferguson JL: Sepsis alters myocardial and plasma concentrations of endothelin and nitric oxide in rats. J Mol Cell Cardiol 29: 1469-1477, 1997
11. Gupta A, Sharma AC: Metalloendopeptidase inhibition regulates phosphorylation of p38-mitogen activated protein kinase and nitric oxide synthase in heart following endotoxemia. Shock 20: 375-381, 2003
12. Bogoyevitch MA, Ketterman AJ, Sugden PH: Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270: 29710-29717, 1995
13. Clerk A, Bogoyevitch MA, Anderson MB, Sugden PH: Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 269: 32848-32857, 1994
14. Liu W, Kato M, Itoigawa M, Murakami H, Yajima M, Wu J, Ishikawa N, Nakashima I: Distinct involvement of NF-κB and p38 mitogen-activated protein kinase pathways in serum deprivation-mediated stimulation of inducible nitric oxide synthase and its inhibition by 4-hydroxynonenal. J Cell Biochem 83: 271-280, 2001
15. Tracey, WR, Tse J, Carter G: Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Therapeut 272: 1011-1015, 1995
16. Pollack JS, Nakane M, Buttery LDK, Martinez A, Springdall JM, Polak JM, Forstermann U, Murad F: Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am J Physiol 265: C1379-C1387, 1993
17. Mazzocchi G, Albertin G, Nussdorfer GG: Adrenomedullin (ADM), acting through ADM (22-52)-sensitive receptors, is involved in the endotoxin-induced hypotension in rats. Life Sci 66(15): 1445-1450, 2000
18. Bone RC: Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and what we do not know about cytokine regulation. Crit Care Med 24: 163-172, 1996
19. Cadenas S, Cadenas AM: Fighting the stranger-antioxidant protection against endotoxin activity. Toxicology 180: 45-63, 2002
20. Suda H, Aoyagi T, Takeuchi T, Umezawa H: A thermolysin inhibitor produced by actinomycetes: Phosphoramidon. J Antibiotics 26: 621-623, 1973
21. Ohnaka K, Takayanagi R, Nishikawa M, Haji M, Nawata H: Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. J Biol Chem 268: 26759-26766, 1993
22. Turner AJ, Murphy LJ: Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51: 91-102, 1996
23. Arriero MM, de la Pinta JC, Escribano M, Celdran A, Munuoz-Alameda L, Garcia-Canete J, Jimenez MA, Casado S, Farre J, Lopez-Farre A: Aspirin prevents Escherichia coli lipopolysaccharide- and Staphylococcus aureus-induced downregulation of endothelial nitric oxide synthase expression in guinea pig pericardial tissue. Circ Res 90, 719-727, 2002
24. Chauhan SD, SeggaraG, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A: Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773-775, 2003
25. Loke KE, McConnell PI, Tuzman JM, Shensely EG, Smith CJ, Stackpole CJ, Thompson CI, Kaley G, Wolin MS, Hintze TH: Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 84: 840-845, 1999
26. DePlaen IG, Qu XW, Wang H, Tan XD, Wang L, Han XB, Rozenfeld RA, Hsueh W: Endotoxin, but not platelet-activating factor, activates nuclear factor-kappaB and increases IkappaBalpha and IkappaBbeta turnover in enterocytes. Immunology 106: 577-583, 2002
27. LaPointe MC, Isenovic E: Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/p44 and p38 MPAK signaling pathways in cardiac myocytes. Hypertension 33: 276-282, 1999
28. McKenna TM, Li S, Tao S: PKC mediates LPS- and phorbol-induced cardiac cell nitric oxide synthase activity and hypocontractility. Am J Physiol 269: H1891-H1898, 1995
29. Kubo T, Ibusuku T, Chiba S, Kambe T, Fukumori R: Mitogen-activated protein kinase activity regulation of angiotensin and endothelin systems in vascular smooth muscle cells. Eur J Pharmacol 411: 27-34, 2001